
AstraZeneca Rhythm Pharmaceuticals Acquisition to Expand Rare Disease Portfolio
AstraZeneca has reportedly made a non-binding offer worth approximately $10 billion to acquire Rhythm Pharmaceuticals, a US-based biotechnology company specialising
AstraZeneca has reportedly made a non-binding offer worth approximately $10 billion to acquire Rhythm Pharmaceuticals, a US-based biotechnology company specialising in treatments …
Boehringer Ingelheim has signed a cancer drug licensing agreement with China’s Sino Biopharmaceutical (SBP Group) that could be worth up to $7.4 …
CVS Health plans to divide its healthcare business into two publicly traded companies, separating its approximately 9,000 retail pharmacies from its insurance …
Australia has approved Novo Nordisk’s daily weight-loss pill, Wegovy, giving eligible patients an oral alternative to the weekly injections. The Therapeutic Goods …
The US Food and Drug Administration (FDA) has granted tentative approval to the first generic version of lenacapavir, a long-acting injection that …
NHS England is introducing a new early warning system in NHS emergency departments across the country to help doctors and nurses identify …
The U.S. Food and Drug Administration (FDA) has issued a warning after Medline reported two deaths and 16 serious injuries associated with …
Hundreds of GP practice websites across England and Wales have gone offline after digital services provider Silicon Practice entered administration, disrupting patients’ …
Taylor Farms of Dallas, Texas, recalled the H-E-B Backyard BBQ Chop Salad Kit because the product may contain undeclared soy and almonds. …
Anthropic has acquired Mithril Medicine, a biotechnology company using artificial intelligence (AI) to develop experimental treatments for rare muscular dystrophy conditions. Completed …
The Therapeutic Goods Administration (TGA) has outlined new testing reforms for sun protection products after a major testing controversy. The new Australian …
Walmart is expanding its digital healthcare marketplace, Better Care Services, through a partnership with General Medicine, giving customers more ways to explore …

AstraZeneca has reportedly made a non-binding offer worth approximately $10 billion to acquire Rhythm Pharmaceuticals, a US-based biotechnology company specialising

Boehringer Ingelheim has signed a cancer drug licensing agreement with China’s Sino Biopharmaceutical (SBP Group) that could be worth up

CVS Health plans to divide its healthcare business into two publicly traded companies, separating its approximately 9,000 retail pharmacies from

Australia has approved Novo Nordisk’s daily weight-loss pill, Wegovy, giving eligible patients an oral alternative to the weekly injections. The

The US Food and Drug Administration (FDA) has granted tentative approval to the first generic version of lenacapavir, a long-acting

NHS England is introducing a new early warning system in NHS emergency departments across the country to help doctors and

The U.S. Food and Drug Administration (FDA) has issued a warning after Medline reported two deaths and 16 serious injuries

Hundreds of GP practice websites across England and Wales have gone offline after digital services provider Silicon Practice entered administration,

Taylor Farms of Dallas, Texas, recalled the H-E-B Backyard BBQ Chop Salad Kit because the product may contain undeclared soy

Anthropic has acquired Mithril Medicine, a biotechnology company using artificial intelligence (AI) to develop experimental treatments for rare muscular dystrophy

The Therapeutic Goods Administration (TGA) has outlined new testing reforms for sun protection products after a major testing controversy. The

Walmart is expanding its digital healthcare marketplace, Better Care Services, through a partnership with General Medicine, giving customers more ways